Anebulo Pharmaceuticals, Inc.
ANEB
$2.30
-$0.01-0.43%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -2.14M | -1.68M | -2.46M | -2.20M | -1.35M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | 17.40K | 245.20K | 59.70K | 59.70K | 59.70K |
Total Other Non-Cash Items | 340.30K | 255.30K | 564.30K | 286.90K | 177.20K |
Change in Net Operating Assets | 135.00K | -426.20K | 433.30K | 164.10K | -939.90K |
Cash from Operations | -1.65M | -1.60M | -1.41M | -1.69M | -2.05M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00 | 0.00 | 15.00M | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00 | -116.70K | -- | -- | 0.00 |
Cash from Financing | 0.00 | -116.70K | 15.00M | -- | 0.00 |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1.65M | -1.72M | 13.59M | -1.69M | -2.05M |